Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Alexza Pharmaceuticals Inc. (ALXA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-15Dec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    Product sales  2.42.60.9     
    Other  2.73.047.0     
Total revenues   [+]5.05.647.84.15.742.99.50.5
            Revenue growth   [+]-9.6%-88.4%1075.4%-28.1%-86.8%350.7%1857.6%-98.9%
Cost of goods sold  21.115.911.20.00.00.00.00.0
Gross profit  -16.1-10.436.64.15.742.99.50.5
            Gross margin  -320.4%-186.4%76.6%100.0%100.0%100.0%100.0%100.0%
Selling, general and administrative   [+]12.213.315.811.111.814.015.417.6
Research and development  11.713.719.121.828.333.539.8 
Other operating expenses  27.18.1     61.6
EBITDA   [+]-64.2-42.25.1-24.5-29.9-0.1-40.8-73.4
            EBITDA margin  -1276.5%-759.1%10.6%-602.9%-528.9%-0.2%-429.1%-15108.2%
Depreciation and amortization  3.03.43.34.34.44.64.95.3
EBIT   [+]-67.2-45.61.8-28.9-34.4-4.7-45.7-78.7
            EBIT margin  -1336.2%-820.1%3.7%-709.4%-607.2%-10.8%-480.0%-16197.5%
Non-recurring items  -27.1-8.1    2.0 
Interest expense  8.47.41.51.42.2  0.9
Other income (expense), net   [+]27.28.2-39.92.3-4.04.8-8.42.6
Pre-tax income  -21.3-36.7-39.6-28.0-40.5-1.5-56.1-77.0
Income taxes  0.00.00.00.00.00.047.60.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0% 0.0%
Minority interest        14.0 
Net income  -21.3-36.7-39.6-28.0-40.5-1.5-70.1-77.0
            Net margin  -424.0%-660.5%-82.8%-687.4%-716.1%-3.5%-736.3%-15852.1%
   
Basic EPS   [+]($1.08)($2.07)($2.38)($2.24)($5.97)($0.27)($2.68) 
Diluted EPS   [+]($1.08)($2.07)($2.38)($2.24)($5.97)($0.27)($2.68) 
   
Shares outstanding (basic)   [+]19.817.816.712.56.85.526.1 
Shares outstanding (diluted)   [+]19.817.816.712.56.85.526.1 
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy